Related Experiment Videos
A comparison of two methods for adaptive interim analyses in clinical trials
1Institut für Medizinische Statistik, Informatik und Epidemiologie, Universität zu Köln, Germany. gernot.wassmer@medizin.uni-koeln.de
Biometrics
|June 18, 1998
Summary
Two methods for two-stage clinical trials allow early stopping if no treatment effect is found. These approaches offer similar statistical performance but differ in practical application and design tools.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Statistical Methods
Background:
- Two-stage adaptive trial designs offer flexibility in clinical research.
- Early termination is possible if interim analysis shows no treatment effect, preserving resources.
- Observed treatment effects can inform subsequent trial stages while controlling Type I error.
Purpose of the Study:
- To compare two proposed methods for two-stage clinical trial procedures.
- To evaluate their statistical performance, including Type I error rate and power.
- To assess their practical applicability and provide guidance for use.
Main Methods:
- Analysis of two-stage procedures proposed by Bauer and Köhne (1994) and Proschan and Hunsberger (1995).
- Derivation of the exact Type I error rate for the Proschan and Hunsberger method.
- Comparison of decision rules, power, and expected sample size between the two methods.
Main Results:
- Both methods allow early stopping for no treatment effect and protect the Type I error rate.
- Decision rules are similar, with negligible differences in power and sample size.
- Significant differences exist in design tools and practical applicability.
Conclusions:
- The Bauer and Köhne, and Proschan and Hunsberger methods offer comparable statistical efficiency for two-stage trials.
- Recommendations are provided based on the practical performance and design considerations of each procedure.
- Choosing between methods depends on specific design needs and practical implementation factors.